Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 22, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 22, Issue 11 (2013)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 22, Issue 11 (2013)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Volume 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

β-blockers: a new role in cancer chemotherapy?

Archana S Nagaraja MS, Nouara C Sadaoui, Susan K Lutgendorf PhD, Lois M Ramondetta MD & Anil K Sood MD

Pages: 1359-1363

Published online: 07 Aug 2013

Abstractforβ-blockers: a new role in cancer chemotherapy? | Full Text | References | PDF (301.9 KB)

1312 Views
18 CrossRef citations
0Altmetric

Free Access

Editorial

Predicting effects of kinase inhibitor in therapy for myeloid malignancies – the challenges in capturing disease heterogeneity

Håkon Reikvam MD PhD, Ina Nepstad MSc & Jerome Tamburini MD PhD

Pages: 1365-1370

Published online: 07 Oct 2013

AbstractforPredicting effects of kinase inhibitor in therapy for myeloid malignancies – the challenges in capturing disease heterogeneity | Full Text | References | PDF (416.9 KB)

546 Views
9 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

Lukas JAC Hawinkels, Amaya Garcia de Vinuesa & Peter ten Dijke

Pages: 1371-1383

Published online: 21 Sep 2013

AbstractforActivin receptor-like kinase 1 as a target for anti-angiogenesis therapy | Full Text | References | PDF (773.3 KB)

777 Views
30 CrossRef citations
0Altmetric

Review Article

Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer

Pavlos Msaouel, Gayathri Nandikolla, Spyros G Pneumaticos & Michael Koutsilieris MD PhD

Pages: 1385-1400

Published online: 12 Sep 2013

AbstractforBone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer | Full Text | References | PDF (531.9 KB)

334 Views
12 CrossRef citations
0Altmetric

Review Article

Metformin in lung cancer: rationale for a combination therapy

Floriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte, Lucia Festino, Anna Manzo, Erika Martinelli, Teresa Troiani, Annalisa Capuano & Fortunato Ciardiello

Pages: 1401-1409

Published online: 12 Aug 2013

AbstractforMetformin in lung cancer: rationale for a combination therapy | Full Text | References | PDF (352.9 KB)

520 Views
22 CrossRef citations
0Altmetric

Review Article

Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia

Paul Lee & Robert A Hegele MD FRCPC FACP

Pages: 1411-1423

Published online: 26 Jul 2013

AbstractforCurrent Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia | Full Text | References | PDF (441.9 KB)

602 Views
18 CrossRef citations
0Altmetric

Review Article

New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor

Shigehiko Mizutani MD PhD, Taihei Tsunemi MD, Eita Mizutani MD PhD, Akira Hattori PhD, Masafumi Tsujimoto PhD & Hiroshi Kobayashi MD PhD

Pages: 1425-1436

Published online: 10 Aug 2013

AbstractforNew insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor | Full Text | References | PDF (682.4 KB)

283 Views
4 CrossRef citations
0Altmetric

Discontinued Drug Perspectives

Article

Discontinued drugs in 2012: cardiovascular drugs

Hong-Ping Zhao, Hong-Min Jiang & Bing-Ren Xiang

Pages: 1437-1451

Published online: 30 Aug 2013

AbstractforDiscontinued drugs in 2012: cardiovascular drugs | Full Text | References | PDF (420.7 KB) | Supplemental

443 Views
5 CrossRef citations
0Altmetric

Article

Discontinued drugs for pulmonary, allergy, gastrointestinal, arthritis (2012)

Sabina Antonela Antoniu MD PhD

Pages: 1453-1464

Published online: 12 Sep 2013

AbstractforDiscontinued drugs for pulmonary, allergy, gastrointestinal, arthritis (2012) | Full Text | References | PDF (306 KB) | Supplemental

335 Views
0 CrossRef citations
0Altmetric

Drug Evaluations

Evaluation of the oral direct factor Xa inhibitor – betrixaban

Michael Palladino PharmD MBA, Geno Merli MD & Lynda Thomson PharmD

Pages: 1465-1472

Published online: 22 Aug 2013

AbstractforEvaluation of the oral direct factor Xa inhibitor – betrixaban | Full Text | References | PDF (411.3 KB)

849 Views
34 CrossRef citations
0Altmetric

The potential role of sunitinib targeting melanomas

Matias E Valsecchi & Takami Sato

Pages: 1473-1483

Published online: 19 Sep 2013

AbstractforThe potential role of sunitinib targeting melanomas | Full Text | References | PDF (509.9 KB)

262 Views
15 CrossRef citations
0Altmetric

Current Phase II clinical data for ridaforolimus in cancer

Anna Spreafico & Helen J Mackay

Pages: 1485-1493

Published online: 21 Aug 2013

AbstractforCurrent Phase II clinical data for ridaforolimus in cancer | Full Text | References | PDF (480.4 KB)

175 Views
4 CrossRef citations
0Altmetric

Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer

Alice C Fan MD, Jennifer J O'Rourke MS, Dave R Praharaj & Dean W Felsher MD PhD

Pages: 1495-1509

Published online: 12 Aug 2013

AbstractforReal-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer | Full Text | References | PDF (611.2 KB)

320 Views
8 CrossRef citations
0Altmetric

Research Article

Article

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

Ling Yang et al.

Article | Published online: 3 Jun 2024

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy

Ava Aghakhani et al.

Review Article | Published online: 30 May 2024

Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration

Shogo Hashimoto et al.

Review Article | Published online: 29 May 2024

Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy

Nadia Saoudi González et al.

Review Article | Published online: 22 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.22, Iss.11, 2013)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?